Human IL-2 ELISA Kit

Contact us
Diaclone
Product Code: 950.010.048
Product Group: ELISA Kits
Supplier: Diaclone
CodeSizePrice
950.010.0481 x 48 Discovery (pre-coated)£207.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Human
Regulatory Status: RUO
Application: Enzyme-Linked Immunosorbent Assay (ELISA)

Further Information

Assay Range:
31.25-1000 pg/ml
Cross reaction:
No cross reactivity with other human cytokines. Cross reactivity with simian IL-2.
Description:
Diaclone ELISA Kits include pre-coated strip plates biotinylated secondary antibody standards controls (where applicable) buffers streptavidin-HRP TMB stop reagents and a detailed procedure.
Detection Target:
IL-2
Incubation:
1h45
Reactivity:
Human
Research Area:
Cytokines / Growth Factors
Sample Size:
100 µl
Sample Types:
Serum Plasma Cell culture supernatant
Sensitivity:
7 pg/ml
Specificity:
Recognizes both natural and recombinant human IL-2

References

  1. Sharma S. et al. Clin Drug Investig. 2020; 40(4): 327?334. . Neuroprotective Role of Oral Vitamin D Supplementation on Consciousness and Inflammatory Biomarkers in Determining Severity Outcome in Acute Traumatic Brain Injury Patients: A Double-Blind Randomized Clinical Trial. https://pubmed.ncbi.nlm.nih.gov/32172522/
  2. Altokka-Uzun G. et al. Cephalalgia 2015: 333102415570762. Oligoclonal bands and increased cytokine levels in idiopathic intracranial hypertension. https://www.ncbi.nlm.nih.gov/pubmed/25697366
  3. Azadbakht L. et al. Diabetes Care2007;30(4):967-73. Soy Consumption Markers of Inflammation and Endothelial Function: A cross-over study in postmenopausal women with the metabolic syndrome. https://www.ncbi.nlm.nih.gov/pubmed/17392557
  4. Blanco B. et al. J. Immunol. 2003 ; 171(2):1070-7 . Induction of human T lymphocyte cytotoxicity and inhibition of tumor growth by tumor-specific diabody-based molecules secreted from gene-modified bystander cells. https://www.ncbi.nlm.nih.gov/pubmed/12847281
  5. Blanco B. et al. Blood 2006;107(9):3575-83. Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines. https://www.ncbi.nlm.nih.gov/pubmed/16282346
  6. Buenestado A. et al. J Parenter Enteral Nutr.2006;30(4):286-96. Olive oil-based lipid emulsion's neutral effects on neutrophil functions and leukocyte-endothelial cell interactions. https://www.ncbi.nlm.nih.gov/pubmed/16804125
  7. Calabia-Linares C. et al. J. Cell Sci.2011; 124(5): 820-830. Endosomal clathrin drives actin accumulation at the immunological synapse. https://www.ncbi.nlm.nih.gov/pubmed/21321329
  8. Casati C. et al. Cancer Res.2003;63(15):4507-15. The apoptosis inhibitor protein survivin induces tumor-specific CD8+ and CD4+ T cells in colorectal cancer patients. https://www.ncbi.nlm.nih.gov/pubmed/12907624
  9. Colarusso C. et al. Biomedicines. 2021 Dec; 9(12): 1931. . Post-COVID-19 Patients Who Develop Lung Fibrotic-like Changes Have Lower Circulating Levels of IFN-β but Higher Levels of IL-1α and TGF-β. https://pubmed.ncbi.nlm.nih.gov/34944747/
  10. Doniz-Padilla L. et al. Eur. J. Endocrinol.2011?; 165(1): 129-136.. Analysis of expression and function of the inhibitory receptor ILT2 in lymphocytes from patients with autoimmune thyroid disease. https://www.ncbi.nlm.nih.gov/pubmed/21551166
  11. Eilertsen G. O. et al. Lupus2011?; 20(6): 607-613.. Interleukin-6 promotes arthritis and joint deformation in patients with systemic lupus erythematosus. https://www.ncbi.nlm.nih.gov/pubmed/21422077
  12. Ge N. L. et al. World J Gastroenterol.2003; 9(10): 2182-5. Prevention of hepatocellular carcinoma in mice by IL-2 and B7-1 genes co-transfected liver cancer cell vaccines. https://www.ncbi.nlm.nih.gov/pubmed/14562374
  13. Giaccone G. et al. Clin Cancer Res. 2002; 8 (12): 3702-9. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. https://www.ncbi.nlm.nih.gov/pubmed/12473579
  14. Goyal S. et al.Ind Psychiatry J. 2017 Jul-Dec;26(2): 201-206.. Immunological changes in depression.. https://www.ncbi.nlm.nih.gov/pubmed/30089970
  15. Gritzapis A. D. et al. Br J Cancer2003; 88(8): 1292-300. Redirecting mouse T hybridoma against human breast and ovarian carcinomas: in vivo activity against HER-2/neu expressing cancer cells. https://www.ncbi.nlm.nih.gov/pubmed/12698199